Skip to main content

Innovation funding

19
Sep 2024

Thirteen projects awarded under the 2025 round of the Efficiency Research program

In July 2024, the Dutch Organization for Health Research and Development (ZonMw) awarded thirteen projects under the 2025 round of the Efficiency Research program, including one project on e-health, one project on extracorporeal treatments, one project in orthopedics, one project in neurology, one project in urology, two projects in obstetrics and gynecology, one project in radiotherapy and one project in the cardiovascular area.
23
May 2024

PECAN tariffs for digital medical devices with therapeutic function released in France

On April 25, 2024, the Ministry of Labor, Health, and Solidarity published an Order in the Official Journal of the French Republic setting the tariffs for digital medical devices with therapeutic functions covered within the early digital support (PECAN) scheme. The tariff for the manufacturer will include an initial lump sum of €435 per patient billable for up to 3 months and a subsequent monthly package of €38.30. The maximum amount of financial compensation is €780 per year per patient.
22
Apr 2024

Decree relating to the RIHN framework reform published in France

On March 31, 2024, the Ministry of Labor, Health, and Solidarity published a Decree in the Official Journal of the French Republic relating to the conditions of coverage of innovative IVD tests within the RIHN framework, which should facilitate the transition from the RIHN framework to regular reimbursement via the NABM Nomenclature.
22
Feb 2024

NHS Cancer Programme Innovation Open Call 3 announced in England

On January 26, 2024, NHS England announced the third round of the Innovation Open Call, funded by the NHS Cancer Programme. All types of late-stage innovations aimed at early detection and diagnosis of cancer are eligible, including medical devices, in-vitro diagnostics, digital health solutions, and AI. Awarded projects will be 100% funded up to the total value of £4 million to produce and evaluate evidence in a real-world setting, supporting adoption and spread by providers, commissioners, and regulators. The application submission will be open on April 8, 2024.